Evidence map›Paper›PMID 40072829›Full record

ReviewJournal of nephrology2025

Hemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification.

Niccolò Morisi, Gaetano Alfano, Marco Ferrarini, Camilla Ferri, Francesco Fontana, Marco Ballestri, Gabriele Donati

Abstract readReview
In one paragraph

Review in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Niccolò MorisiNephrology Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena, Via del pozzo 71, 41122, Modena, Italy.
Gaetano AlfanoNephrology Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena, Via del pozzo 71, 41122, Modena, Italy.
Marco FerrariniDepartment CHIMOMO, University of Modena and Reggio Emilia, Modena, Italy.
Camilla FerriDepartment CHIMOMO, University of Modena and Reggio Emilia, Modena, Italy.
Francesco FontanaNephrology Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena, Via del pozzo 71, 41122, Modena, Italy.
Marco BallestriNephrology Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena, Via del pozzo 71, 41122, Modena, Italy.
Gabriele DonatiNephrology Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena, Via del pozzo 71, 41122, Modena, Italy. gabriele.donati@unimore.it.ORCID http://orcid.org/0000-0001-8549-1221

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adsorption technique has opened a new frontier in the field of purification through hemodialysis. This technique has proved to be effective in removing uremic toxins previously deemed inaccessible due to their size or charge, as well as to their molecular interactions with blood proteins. In this context, this review provides a detailed explanation of the role of Polyester-polymer alloy (PEPA®) membranes and hemodiafiltration with endogenous reinfusion. The polyester-polymer alloy membrane is a three-layered dialysis membrane with adsorbent properties, representing an innovative approach to engineering the filter membrane to achieve adsorbent characteristics while maintaining biocompatibility with blood. Haemodiafiltration with endogenous reinfusion is a technique where a first filter separates plasma water from blood, then plasma water is led to a sorbent cartridge. After contact with the sorbent, the purified plasma water reconstitutes the whole blood, which is led to a second filter where diffusion takes place. Both techniques are efficacious in removing middle-molecular weight molecules and protein-bound toxins, and have a role in reducing inflammation and erythropoietin resistance. However, the additional clinical advantage of adsorption is partially offset by lack of selectivity in the absorption process, potentially resulting in the loss of micro- and macronutrients or drugs. Therefore, further studies are encouraged to evaluate the impact of absorption on patient outcomes and clinical applicability in certain medical conditions.

Indexed as

HemodiafiltrationMembranes, ArtificialRenal DialysisUremic ToxinsAdsorptionAlloysHumansPolyestersAlloysMembranes, ArtificialPolyestersUremic ToxinsHemoadsorptionHFRPEPAPlasma adsorptionUremic toxins

Identifiers

PMID40072829
PMCPMC12165880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.